Related content

Antiangiogenic Therapy for High-Grade Gliomas

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 3, 2009-07 ,pp. : 184-194

Bentham Science Publishers

Access to resources Recommend Favorite

Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection

By Mackiewicz Andrzej   Mackiewicz Jacek   Wysocki Piotr J.   Wiznerowicz Maciej   Kapcinska Malgorzata   Laciak Maria   Rose-John Stefan   Izycki Dariusz   Burzykowski Tomasz   Karczewska-Dzionk Aldona  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 6, 2012-06 ,pp. : 773-783

Informa Healthcare

Access to resources Recommend Favorite

Carmustine implants costly in high-grade gliomas

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Adjuvant temozolomide improves long-term survival in glioblastoma

By  

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: First report of long-term results

By Uhl Matthias   Mattke Matthias   Welzel Thomas   Oelmann Jan   Habl Gregor   Jensen Alexandra D.   Ellerbrock Malte   Haberer Thomas   Herfarth Klaus K.   Debus Jürgen  

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1579-1585

Blackwell Publishing

Access to resources Recommend Favorite